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The outcome of a virus infection represents an imbalance toward either the infecting 
agent's virulence or the host's ability to limit virus spread.  Limiting infection may be 
a  function  of the  immune  system  and  take  the  form of a  specific  response  and/or 
result from a nonimmune (nonspecific) response. Recently, considerable attention has 
focused on nonspecific host responses because of their potential to halt or reduce viral 
replication  early  in  infection  before  the  generation  of either  specific  antibodies  or 
cytotoxic T  lymphocytes. Examples of early antiviral mechanisms are serum comple- 
ment that can lyse some virions (1, 2) and bind to infected cells (3-5) in the absence 
of antibodies,  natural  killer  (NK) 1 cells  (6)  that  lyse both  infected  and  uninfected 
target cells (7, 8), and interferon, which can inhibit viral replication  (9-12)  as well as 
induce new or enhance ongoing NK cell activity (13-16). 
The  induction  or enhancement  of nonspecific  cell-mediated  cytotoxicity  (CMC) 
(also  called  spontaneous  CMC,  natural  CMC,  or  NK  activity)  by  viruses  and/or 
interferon has recently received much attention  (6-8, 17-22). However, little is known 
about the role of viral polypeptides in induction or enhancement of this CMC. Early 
in infection, viral glycoprotein may be expressed on the surface of infected cells  (23) 
before its release either into the fluid phase in soluble form or its incorporation into 
virions.  For  this  reason,  we studied  the  role  of and  mechanism(s)  whereby soluble 
viral glycoproteins, viral glycoproteins inserted  into artifical membranes  (virosomes), 
and whole virions mediate nonspecific CMC. 
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We found that  purified  measles  virus  glycoproteins in a  soluble  form or inserted 
into phospholipid  vesicles induced significant  cytotoxic activity in peripheral  blood 
lymphocytes (PBL)  within  2-4 h  of incubation.  This CMC was expressed  as lysis of 
autologous or heterologous cells and was not associated with the release of interferon 
in culture fluids. In contrast, whole virions required >8 h  to generate the same degree 
of cytotoxic activity. This activity was associated with interferon release in the culture 
fluids.  Glycoproteins  purified  from  lymphocytic  choriomeningitis  virus  (LCMV) 
duplicated this result, suggesting that these findings may be a  generalized phenome- 
non. 
Materials  and Methods 
Virus  Source,  Purification  of  Viral Polypeptides,  and  Their  Integration  in  Artificial  Lipid 
Membranes.  Measles virus and LCMV were used in this study. The source of measles  virus, its 
cloning, passage history, method of propagation handling, and titration have been reported by 
this laboratory (3, 24, 25). To label virus, infected HeLa cells were incubated for 24 h in leucine- 
free Dulbecco's modified Eagle's minimum essential medium (MEM) supplemented with  10% 
heat-inactivated dialyzed fetal bovine serum  (FBS)  (Flow Laboratories, Rockville, Md.),  1% 
glutamine, penicillin (100 IU/ml), streptomycin (100 #g/ml), and 6.25/zCi/ml of [3H]leucine 
(Amersham/Searle Corp., Arlington Heights, Ill.).  Culture fluid containing measles virus was 
freed from debris by an initial centrifugation at  1,500 g for 30 min at 4°C and the virus was 
then purified as described by this laboratory (24, 25). To prepare hemmagglutinin (HA) and 
fusion (F) glycoproteins, purified virus solubilized in 0.15  M  NaC1,  0.01  M  Tris-HCl buffer, 
(Tris-NaCl  buffer),  pH  8.0,  containing  2%  Nonidet  P-40  (NP-40)  (BDH Chemicals,  Poole, 
England) was applied to a column of Sepharose beads bearing covalently linked Lens culinaris 
agglutinin  (LCH Gel;  E,  Y.  Laboratories Inc., San  Mateo,  Calif.)  (25).  After adsorption of 
applied material, the column was washed with Tris-NaCl buffer containing 0.1% NP-40, which 
was later replaced with Tris-NaC1 buffer containing 30 mM octyl-fl-n-glucopyranoside (octyl- 
glucoside; Calbiochem, La Jolla, Calif.).  Solid-phase-bound measles virus glycoproteins were 
then  eluted  using Tris-NaCl  buffer containing 30 mM octylglucoside and 0.1  M  a-methyl- 
mannoside. Protein concentration was determined by the Lowry method (26). As a control, a 
Sepharose-lentil-lectin column was run under similar conditions except that no solubilized virus 
was added.  The fraction eluted  from this column by a-methyl-mannoside was found to be 
protein  free.  The source, cloning, preparation,  and handling of LCMV have been described 
(27). LCMV glycoproteins were purified by affinity choromatography with two serial  passages 
through a  lentil-lectin column using 2% sodium cholate as a  detergent.  The purity of viral 
glycoproteins preparations were assayed by electrophoresis on sodium dodecyl sulfate-polyacryl- 
amide gels  (SDS-PAGE) (25). Purified glycoproteins and the equivalent fraction eluted from 
the control column were freed of detergent by exhaustive dialysis at 4°C against phosphate- 
buffered saline (PBS). The integration of purified measles virus glycoproteins into lipid vesicles 
was carried out using egg yolk phosphatidylcholine (EYPC)  (Sigma Chemical Co., St.  Louis, 
Mo.)  as  reported  (25).  Traces of all-labeled  measles  virus glycoproteins and  of 14C-labeled 
EYPC were used to check the integration of glycoproteins into the membranes by flotation 
gradient ultracentrifugation analysis (25). 
Immunochemical Reagents and SDS-PAGE.  Antibody to measles virus glycoproteins was ob- 
tained  from  the  serum  of a  patient  with  subacute  sclerosing  panencephalitis  (SSPE)  and 
accounted for 10% of the total immunoglobulin (28). IgG antibodies and their F(ab')2 fragments 
were prepared  as reported  (3). Serum  from a  healthy donor  (SH)  with  no detectable  anti- 
measles  virus antibodies,  as  assayed by neutralization,  fluorescent  binding to virus-infected 
cells,  and  immune precipitation  tests with 35S-labeled  measles virus  (24,  29),  was used  as a 
source of IgG or  F(ab')2  free of anti-measles  viral  antibodies.  SDS-PAGE analysis of viral 
polypeptides was performed as described by Laemmli (30) and modified in this laboratory (24, 
25). 
Cytotoxicity Studies.  PBL obtained from healthy measles immune and nonimmune subjects 
were used as effector cells in all cytotoxicity assays. Lymphocytes were obtained from heparin- 842  INDUCTION OF CYTOTOXIC  LYMPHOCYTES  BY  VIRAL GLYCOPROTEINS 
ized peripheral blood centrifugated on a  Ficoll-Hypaque gradient (31) and freed of adherent 
cells by incubation for  1 h  at  37°C  with 5% COs in a  tissue culture flask (175  cm2;  Falcon 
Labware,  Oxnard,  Calif.).  To  obtain  lymphocyte subsets,  PBL  were  first  incubated  with 
neuraminidase- (Gibco Laboratories, Grand Island Biological Co., Grand Island, N. Y.) treated 
sheep erythrocytes (SRBC) (32) and segregated into erythrocyte-rosette forming (E  +) cells and 
non-E-rosette forming (E-) cells by application to a  Ficoll-Hypaque gradient.  Lymphocytes 
with (C3 +) and without (C3-) receptors for C3 were separated by using a column of Sepharose 
4B beads (Pharmacia Fine Chemicals, Piscataway, N. J.)  bearing activated human C3 mole- 
cules, as previously described (33).  Lymphocytes bearing receptors for the Fe portion of IgG 
(Fe-positive cells) were  removed  from  PBL  by using a  monolayer made of ox erythroeytes 
(ORBC)  coated with rabbit anti-ORBC IgG. Tissue culture flasks (T-25;  Falcon, Labware) 
previously treated with  PBS  containing  100/~g/ml of poly-L-lysine (70,000  mol wt)  (Sigma 
Chemical Co.) were coated with ORBC during a  2-h incubation at room temperature. After 
washings, bound ORBC were allowed to react for 45 min at 37°C with an excess of rabbit anti- 
ORBC IgG. The erthrocyte antibody (EA) monolayer was then used to absorb Fc-positive cells 
by incubation for 1 h at 37°C. Under similar conditions, PBL were applied to an E monolayer 
(prepared as described for the EA monolayer, but without antibodies) to determine their degree 
of nonspecific binding. 
Cell lines used as targets in this study were: adult human skin fibroblasts (for autologous 
cytotoxicity assays) and human fetal skin fibroblasts established in culture in our laboratory, 
K562  ceils, rhabdomyosarcoma cells (RDMC;  from  the  Wistar Institute)  and  Molt-4 cells. 
Fibroblasts and RDMC were cultured in MEM supplemented with  1% glutamine, 10% FBS, 
and antibiotics; K562  and Molt-4 cells were cultured in RPMI  1640 medium supplemented 
with 10% FBS, 1% glutamine, and antibiotics. 
Cytotoxicity assays were carried out in 96-well plates (Costar, Cambridge, Mass.) using 5aCr- 
labeled target ceils as described (28) with slight modifications. Specific lysis was calculated by 
sx  the following formula: where Spo is the  Cr release from targets in the presence of medium 
alone, Max is the SlCr release of target cells after treatment with 1% NP-40, and Sam is the 51Cr 
release by the sample to be tested: 
Sam -  Spo 
percent specific release -  X  100. 
Max -  Spo 
In most experiments, the effector to target cell ratio used was  100:1.  When three effector to 
target cells ratios were used (100: l, 50:1, and 25:1), specific cytotoxicity was computed in lytic 
units (LU) over the number of effector cells by a modification of the Von Krogh equation (34). 
One LU is expressed as the number of lymphocytes required to lyse 50% of the target cells 
during the incubation time specified. All test cultures and controls were run in triplicate. Most 
often fibroblasts were subject to an 18-h assay; spontaneous release did not exceed 30%. Kinetic 
experiments with 51Cr-labeled fibroblasts as targets were designed as follows: at time 0, four 
plates containing identical reagents were set up and incubated at 37°C in 5% CO2. Each plate 
51  included samples for  analysis of both  spontaneous  and  maximal  release from  Cr-labeled 
targets. At varying time-points, 200 pl of supernatant fluid was harvested from each well, 100 
/~l for determining SlCr release and 100/~l for titrating interferon-like activity. 
Interferon Assay.  Interferon activity of supernatant fluids was tirated as their ability to inhibit 
the  cytopathic effects of vesicular stomatitis virus  (VSV')  on  a  monolayer of Vero cells as 
described by Dahl  (35) with minor modifications. All titrations were carried out in triplicate 
and interferon units were expressed as the reciprocal of the dilution inhibiting cytopathic effects 
by 50%. Each assay included Vero cells treated with a reference interferon preparation (National 
Institutes of Health  Reference  Interferon G-023-901-5271).  Under  the conditions used, one 
interferon unit derived in experiments was equivalent to one reference unit of NIH Human 
Reference Interferon. 
Results 
Soluble Measles Virus Glycoproteins Induced CMC.  We first determined whether soluble 
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human donors to kill heterologous and/or autologous fibroblast targets. Either 600 ng 
of purified  measles  virus  glycoproteins,  3,000  ng  of untreated  or  ultraviolet  light 
(UV)-inactivated measles virions, or PBS was mixed with  106, 5 ×  l0  s, or 2.5 ×  105 
PBL and SlCr-labeled target cells, and the specific SlCr release was determined over 
an  18-h period. Table I  shows that PBL from all nine individuals studied mediated 
cytotoxicity. PBL incubated with untreated or UV-inactivated virions released sig- 
nificantly more 51Cr from both autologous and  heterologous targets than did  PBL 
incubated in PBS (P -- <0.02). Soluble measles virus-glyeoproteins induced as much 
or more killing by PBL as whole virions. One of the nine individuals,  SH, had no 
history of measles virus infection and no antibody to measles, but her PBL were as 
effective as  PBL from immune adults  in  inducing CMC  after exposure to measles 
virus glycoproteins. Results were similar when PBL from these subjects were incubated 
with measles virus glycoproteins and tested against Molt-4, K-562, or RDMC target 
cells in  a  4-h 51Cr release assay  (data  not  shown).  In contrast, incubation of these 
targets with virus glycoproteins in the absence of PBL did not yield any significant 
lysis. Additionally, the eluted fraction from a control Sepharose lentil-lectin column, 
devoid of measles virus glycoproteins, also failed to induce CMC. 
We next determined the amounts of soluble measles virus glycoproteins required to 
cause PBL killing of target cells and the kinetics of lysis.  Equivalent amounts of free 
glycoproteins and of glycoproteins associated with measles virions were studied  for 
their induction of CMC. This was accomplished by using virions at protein concen- 
tration five times higher than  that  of soluble measles virus  glycoproteins. Previous 
studies  with  lentil-lectin  affinity chromatography indicated  that  glycoproteins ac- 
counted for -20% of the whole virion protein (25). By establishing a  dose-response 
curve, we noted a  linear relationship between the amount of glycoproteins present 
and  the percentage of specific 51Cr released from autologous fibroblasts in an  18-h 
assay (Fig.  1). As little as 100 ng of virus glycoproteins/108 PBL resulted in CMC. 
TABLE I 
Lysis of Heterologous and Autologous Fibroblasts by Human PBL in the Presence  of Measles Virus Virions 
or Its Glycoproteins* 
PBL incubated  with 
Donor~ 
PBS only  Virions  Soluble virus glycoproteins 
Untreated  UV-inactivated 
Heterologous  Autologous  Heterologous  Autologous 
Heterologous  Autologous  Heterologous  Autologous 
JH  24  9  81  84  80  82  84  79 
MO  t6  34  79  73  75  70  138  131 
PS  14  60  74  80  73  80  178  179 
FD  57  15  95  141  90  135  191  211 
AB  81  --  208  --  205  --  275  -- 
BH  20  --  171  --  180  --  238  -- 
CB  3  --  96  --  92  --  235  -- 
LK  3  --  142  --  109  --  138  -- 
SH  10  --  155  --  145  --  158  -- 
25.9~±  26.2  30±  22.2  122.6 ±  48.2  95.0 ~  31.0  116.8 ±  48.8  91.9 ~  29.1  181.9 ~  5%9  150.2 ±  57.4 
* An  18-h blCr release  assay was used, and  the data  are presented as LU/108  PBL. The  release of ~lCr from target cells alone over this timed 
period did not exceed  30%. 
:~ SH  was  a  donor  with  no clinical  history  of measles  virus  infection  and  no detectable  circulating anti-measles  virus  antibodies.  All  other 
donors had detectable  levels of anti-measles  virus antibodies. 
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Fro.  1.  Dose-response  curve of CMC induced by measles virus. PBL were incubated with 5ZCr- 
labeled autologous fibroblasts in the presence of increasing amounts of measles virus glycoproteins 
(0), whole virions (I-I), or PBS (A). The effector to target cell ratio was 100:1 and the assay time 
was 18 h. 
Cell Binding Requirements of Measles  Virus Glycoproteins  for CMC.  Next we determined 
whether  the  binding  of virus  glycoproteins  to  the  surfaces  of PBL  and/or  target 
fibroblasts was sufficient to induce CMC. After 1 ×  106 PBL or 1 X  104 51Cr-labeled 
autologous flbroblasts were preincubated with varying amounts of virus glycoproteins 
for 2 h  at 37°C, the cells were either washed extensively to remove free glycoproteins 
or were transferred unwashed  with their culture fluid  (containing soluble glycopro- 
teins) to plates containing untreated 51Cr flbroblasts and PBL, respectively. We found 
that PBL exposed to virus glycoproteins, washed, and then added to flbroblast targets 
induced CMC,  but approximately six times more glycoproteins (2,900 ng/106 PBL) 
were needed to reach 50% lysis than when soluble viral glycoproteins were kept in the 
incubation  fuids  (500 ng/106  PBL)  (Fig.  2A).  Similar results occurred when whole 
virions were used.  CMC was induced  when 51Cr-labeled fibroblasts were incubated 
with  viral  glycoproteins,  washed,  and  added  to  untreated  PBL.  10  times  more 
glycoproteins (> 10 #g/104 flbroblasts) were needed to achieve 50% of lysis than when 
the soluble glycoproteins were kept in the culture fluid  (1.0 #g/104  fibroblasts)  (Fig. 
2 B). Radiolabeling studies showed that at  1.0/zg/106 PBL or 104 fibroblasts, ~2% of 
offered  measles  virus  glycoproteins  became cell  associated  under  the  experimental 
conditions used. Hence, these studies indicated first that viral glycoproteins bound to 
fibroblasts could induce cytotoxic activity in unprimed PBL, and second, that as little 
as  10-20 ng viral glycoprotein bound to 106 PBL induced significant CMC. 
Inhibition  of Measles  Virus  Glycoprotein-induced CMC  by  Anti-Measles  Virus  Antibody. 
F(ab')2 fragments from an IgG fraction containing high titers of antibodies to measles 
virus and an IgG fraction devoid of anti-measles virus antibodies were compared for 
their ability to inhibit  measles virus glycoprotein-induced CMC.  PBS or PBS  con- 
taining F(ab')2 antibody in  decreasing amounts  from 4,500  to 4.4/zg were mixed a 
fixed amount of either measles virus glycoproteins (1.0/zg) or whole measles virus (5.0 
#g)  and incubated  for  1 h  at  37°C.  Each mixture was then added  to PBL  (1/zg of 
glycoproteins/106 cells) and 5ZCr-labeled autologous flbroblasts, and the specific 51Cr 
release was determined  over  18 h  (Fig.  3A).  F(ab')2 antibody to measles virus  (562 CASALI,  SISSONS,  BUCHMEIER,  AND  OLDSTONE  845 
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FIG.  2.  Binding of measles virus glycoproteins to PBL or fibroblasts and enhancement of CMC. 
Panel  A:  resultant cytotoxlcity against 5~Cr-labeled autologous  fibroblasts. PBL incubated with 
increasing amounts of viral glycoproteins were transferred with fluid-phase glycoproteins (0) or in 
the absence of soluble glycoproteins (O)  into culture wells containing 51Cr-labeled heterologous 
fibroblasts. Panel B: 51Cr-labeled heterologous fibroblasts were incubated with increasing amounts 
of measles virus  glycoproteins and  then  left  in  culture  with  glycoproteins (0)  or  glycoprotein 
containing medium was removed (O). Thereafter, untreated PBL were added. In both experiments, 
the effector to target cell ratio was 100:1 and the assay time was 18 h. 
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Fro.  3.  Blocking of measles virus glyeoprotein-induced CMC by anti-measles virus F(ab')2. Panel 
A: measles virus glyeoproteins were incubated with PBS containing decreasing amounts of F(ab')2 
free of antibodies to measles virus (0) or PBS containing F(ab')2 with antibodies to measles virus 
(O) and then added to umprimed lymphocytes and 5*Cr-labeled autologous fibroblasts. The effeetor 
to targer cell ratio was 50:1  and the assay time was  18 h. Panel B:  incubation of PBL previously 
exposed to measles virus glycoproteins with anti-measles virus F(ab')2. PBL were incubated for 2 h 
with increasing amounts of glycoproteins, washed, mixed with an  excess of nonimmune (0)  or 
immune F(ab')~ (O)  or PBS (A) and added to 51Cr-labeled autologous fibroblasts. The effector to 
target cell ratio was 100:1 and the assay time was 18 h. 
#g//~g glycoproteins) inhibited the cytotoxicity induced in PBL by both viral glyco- 
protein  and whole virus  by as much  as  87  and  45%,  respectively. In  comparison, 
nonimmune F(ab')2 was not effective (Fig. 3 A). 
Next, the ability of F(ab')2 antiviral antibody to block the cytotoxicity of PBL that 
have been already exposed to virus glycoproteins was studied. Various amounts of 
glycoproteins (45-5,800 ng) were incubated with 106 PBL for 2 h at 37°C. The PBL 
were washed extensively and added to either PBS, PBS containing F(ab')2 antibody 
(600/.tg/106 PBL) to measles virus, or F(ab')2 (600 #g/106 PBL) preparation without 
antibody to measles virus. The mixtures were incubated with ~ZCr-labeled  autologous 846  INDUCTION OF CYTOTOXIC LYMPHOCYTES  BY VIRAL GLYCOPROTEINS 
fibroblasts and the amount of 51Cr released over 18 h was determined.  As seen in Fig. 
3 B, antibody to measles virus added to PBL previously exposed to virus glycoproteins 
did not abrogate their ability to lyse target cells. 
PBL Subsets  Responsible for  Viral Glycoproteins Induced  CMC.  Positive  and  negative 
selection  experiments  to determine  the effector PBL subsets  involved in CMC  were 
performed with PBL from two donors for each of the two separate experiments. Total 
PBL,  E ÷  cells,  E-  cells,  E-C3-  cells,  Fc  ÷  cells,  and  Fc-  cells  were  assessed  for  the 
capacity  to  mediate  CMC  against  SaCr-labeled  fibroblasts  in  the  presence  of PBS, 
PBS  containing  900  ng  of measles  virus  glycoproteins,  or  whole  measles  virions 
containing 4,500 ng of protein.  As seen in Fig. 4, the Fc  + PBL subset,  not Fc- cells, 
exerted  CMC.  Assays of other markers in PBL subsets placed CMC activity both in 
E + and E- cells, but E- and C3- cells were the highest in activity. Hence, lymphocytes 
with  and without  E  receptors  mediate  cytotoxicity induced  by measles  virus glyco- 
proteins.  The non-E-rosetting PBL mediating CMC are C3 receptor negative.  How- 
ever,  all  PBL mediating  cytotoxicity induced  by measles  virus  glycoproteins or by 
measles virus have Fc receptors. 
Segregation  of  CMC  Induced  by  Soluble  Virus  Glycoproteins from  That  Induced  by 
Virions.  Unexpected  but  significant  differences in the time-course of CMC  activity 
occurred when PBL were incubated with either soluble measles virus glycoprotein or 
untreated or UV-inactivated virions. As demonstrated in Fig. 5A and C, as soon as 4 
h  after adding 900 ng of soluble measles  virus glycoproteins to  106 PBL, significant 
lysis of 5aCr-labeled  autologous fibroblasts occurred.  In marked contrast,  equivalent 
lysis of fibroblasts by PBL incubated with untreated or UV-inactivated virions (4,500 
ng of protein content) required 8 h or more of incubation. This difference in the early 
induction of CMC by soluble virus glycoprotein as compared with the later induction 
by whole virions was repeatedly observed  in all  experiments  using PBL from eight 
individuals.  Maximal  51Cr release  occurring at  18  h  was  similar  whether  the  PBL 
were incubated with soluble glycoproteins or virions. 
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Flo. 4.  Subsets of PBL responsible for CMC  induced by viral glycoproteins. PBL or various 
subsets were assayed in the presence of PBS (WJ), measles virus glycoproteins (f'l), or whole measles 
virus (m). Panel A: positive selection experiment. PBL, nonadherent cells; E  +, lymphocytes forming 
rosettes with SRBC; E-, lymphocytes not forming rosettes with SRBC; E-C3-, lympbocytes not 
forming rosettes with  SRBC and without  surface receptor for C3.  Panel B: negative selection 
experiment.  Fc  + and  Fc-  PBL with  or without  surface receptor for the Fc  fragment  of IgG, 
respectively. In all experiments, the target cells were heterologous fibroblasts and the assay time was 
18 h. The data represented were obtained by PBL from two donors. PBL from two other donors 
performed similarly. CASALI, 
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To further segregate these differences,  we questioned  whether soluble  viral glyco- 
proteins or virions from measles virus induced interferon-like activity in the superna- 
tant fluids by PBL. In Fig. 5, panels B and D  show that interferon was released  into 
the culture medium only when untreated or UV-inactivated  virions were present  in 
culture with PBL. Interferon production peaked between 8 and  12 h, after which no 
further increase was demonstrable up to 18 h. The material was interferon-like in that 
it inhibited VSV replication, lost activity after trypsin treatment, and was not pelleted 
by uhracentrifugation  (100,000 g/h).  In none of our experiments did soluble measles 
virus  glycoproteins incubated  with  PBL induce release  of interferon-like  activity in 
the culture medium. These findings were consistently reproduced and noted in PBL 
from several individuals. 
We next determined whether the supernatant fluids harvested from the PBL-soluble 
glycoprotein cultures or from the PBL-virions cultures were able to induce CMC  in 
newly added PBL. For this experiment,  1 ×  106 PBL were incubated for 1 h  at 37°C 
with  either soluble  measles  virus  glycoproteins  (1,200  ng),  virions  (6,000  ng protein 
content), or PBS, and were washed and added to SlCr-labeled or unlabeled autologous 
fibroblasts, or incubated without fibroblasts.  After 6,  12, and  18 h  of incubation,  150 
/~1 of supernates  from various cultures was UV-irradiated  for 5  min and then added 
with untreated  PBL and 5XCr-labeled fibroblasts in a  6-h culture. The degree of lysis 
achieved in the primary cultures is represented  in Fig. 6 A. Results shown in Fig. 6 B 
indicate that media from PBL treated with whole virus and incubated with or without 
fibroblasts  consistently  induced  CMC.  In contrast,  media  from  PBL preincubated 
with purified glycoproteins or PBS only, either in the presence or absence of fibroblasts, 
failed to induce cytotoxic activity in newly added PBL. 
Induction of CMC by Measles  Virus Glycoproteins Integrated into Lipid Bilayers.  We next 
determined  whether  these  glycoproteins must  be extracted  from the  viral  envelope 848  INDUCTION OF CYTOTOXIC  LYMPHOCYTES  BY VIRAL GLYCOPROTEINS 
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Fro. 6.  Recruitment  of cytotoxic lymphocytes by fluids from cultures of PBL and measles virions 
or  PBL  and  soluble  glycoproteins.  Panel  A:  CMC  by  PBL  preincubated with  measles virus 
glycoproteins (Q), virions (f"i), or PBS (&), washed and cultured with  5aCr-labeled heterologous 
fibroblasts  for the  indicated time.  The effector to target cell ratio was  100:1. Panel  B:  CMC 
induction  by culture fluids from PBL and measles virions with (')  or without  (D) fibroblasts; 
culture fluids from PBL and glycoproteins with (O) or without  (O) fibroblasts; culture fluids from 
PBL  incubated with  PBS  in  the presence of fibroblasts  (A). Culture  fluids were harvested  at 
indicated time. The effector to target cell ratio was 100:1 and the assay time was 6 h. 
and  presented  in  a  free  form  to  induce  CMC,  as  in  the foregoing experiments,  or 
whether  this  activity is retained when  the  glycoproteins are integrated into  a  lipid 
bilayer. First, different amounts of purified measles virus glycoproteins from 28 ng to 
3,600 ng, free or inserted into lipid bilayers, were added to 106 PBL and cultured with 
1 ×  104  51Cr-labeled autologous fibroblasts. The  amount  of 51Cr released over  18  h 
was  then  determined.  In  a  second  study,  106  PBL  were  incubated  with  900  ng  of 
purified measles virus glycoproteins, either in soluble form or integrated into vesicles, 
and  104 51Cr-labeled fibroblasts. The 51Cr release was measured after 4, 8,  12, and  18 
h. 
As shown  in Fig.  7,  measles virus glycoproteins inserted into artificial lipid mem- 
branes enhanced CMC  to the same extent as an equivalent amount  of their soluble 
counterparts (panel A), and with the same kinetics (panel B). Vesicles with integrated 
glycoprotein spikes (virosomes)  did not  induce release of mediators with  interferon- 
like activity in the culture medium (data not shown). EYPC vesicles without the virus 
glycoproteins, "naked vesicles," did not induce any CMC  against fibroblasts. 
Effect  on  CMC of Combining Measles  Virus  Glycoproteins and  Virions.  To  determine 
whether the virus glycoproteins and virions had an additive effect in inducing CMC, 
106 PBL were incubated with 104 51Cr-labeled fibroblasts and 1.2 #g of soluble measles 
virus  glycoproteins,  virions  of  measles  virus  containing  6  #g  of protein,  or  both 
glycoproteins (1.2 #g)  and virions (5 #g of protein). As seen in Fig. 8A, by  12 h  after 
incubation,  the combined  reagents  (glycoprotein and  virion)  caused  a  lower CMC 
value  than  that  resulting  from  incubation  with  measles  virus  glycoproteins alone. 
Results with  UV-inactivated virions were  similar to untreated  virions. At  18  h,  the 
combined effect of the two reagents was similar to that of glycoproteins or virus alone. 
The soluble measles virus glycoproteins did not interfere with the release of interferon CASALI,  SISSONS,  BUCHMEIER,  AND OLDSTONE 
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FIG. 7.  CMC induced by measles virus glycoproteins integrated into artificial lipid membranes. 
Panel A: dose-response curve of CMC by PBL incubated with soluble measles virus glycoproteins 
(O), glycoproteins integrated into artificial  membranes  (O), and vescieles made with EYPC only 
(A). Panel B: kinetic study of CMC by PBL incubated with 51Cr-labeled  autologous fibroblasts and 
soluble measles virus glycoproteins (Q), glyeoproteins integrated into artificial membranes  (C)), or 
PBS (&). In both experiments, the effector to target cell ratio was 100:1 and the assay time was 18 
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activity induced by the virions  (Fig. 8B),  because this activity was equal  in culture 
fluids containing virions alone or with virions mixed with the glycoproteins. 
Soluble LCMV Glycoproteins Induced CMC.  PBL from several of the individuals tested 
above also killed human  fibroblasts after incubation with purified LCMV  glycopro- 
teins and were evaluated by the same criteria used for measles virus. Purified LCMV 
glycoproteins enhanced  CMC  in a  dose-response fashion as did measles virus glyco- 
proteins  (Fig.  1)  and  LCMV  glycoprotein bound  to the  PBL  as shown  for measles 
virus glycoproteins (Fig. 2).  In fact, LCMV  soluble glycoproteins and whole virions 
behaved  like  the  measles  virus  components  in  all  parameters  cited  in  this  paper. 
Specifically, LCMV  glycoproteins induced CMC  faster than did whole LCM virions, 
and  combining  LCMV  soluble  glycoproteins  and  whole  LCMV  virions  failed  to 
produce  a  cumulative  CMC  effect.  Additionally,  only  the  virions,  not  purified 
glycoproteins, induced release of interferon by PBL. Further, purified LCMV  nucleo- 
capsids failed to induce CMC  under similar experimental conditions. 850  INDUCTION  OF  CYTOTOXIC  LYMPHOCYTES  BY  VIRAL  GLYCOPROTEINS 
Discussion 
Here we report a novel mechanism by which CMC can be initiated and expressed. 
Purified soluble measles virus  HA and  F  glycoproteins alone or inserted into lipid 
bilayers induce or enhance human PBL killing of a  variety of target cells including 
autologous and  heterologous human  fibroblasts,  Molt-4,  K-562,  and  RDMC  cells. 
Studies of the kinetics of CMC  induction,  the absence of interferon in  the culture 
fluids, and the inability of supernates to recruit cytotoxie activity from newly added 
PBL distinguish this type of nonspecific human CMG from the interferon-associated 
enhancement of NK cell activity (13,  17, 20).  The segregation of various nonspecific 
CMC  activities  is  outlined  in  Table  II.  Cells  involved  in  these  different  effector 
mechanisms cannot yet be separated into discrete subsets according to conventional 
surface markers (Fig. 4). 
The killing of target cells by PBL induced with soluble measles virus glycoproteins 
was efficient and occurred early. After first exposing PBL to glycoproteins and then 
transferring them to cultures of 51Cr-labeled targets, we found that as little as  10 ng 
of glycoprotein bound to PBL induced CMC. Further, kinetic studies showed that in 
most  experiments, significant  lysis  (20-40%  of total  specific 51Cr release)  occurred 
within  2-4 h  of exposing target cells to PBL in the presence of viral glycoproteins. 
Virus glycoproteins inserted into lipid bilayers performed similarly, indicating that 
the activation of PBL was not dependent on the hydrophobic region of the glycopro- 
teins.  Previous electron microscopic and  binding activity studies  in this laboratory 
(25) have indicated that the hydrophobic parts of the measles virus glycoproteins are 
inserted into the vesicle's lipid bilayer and that the "spike projections" are arranged 
in patterns identical to those in virions. In contrast to this activity of free glycoproteins 
or  glycoproteins inserted  into  lipid  bilayers, measles  virion-induced CMC  in  PBL 
takes three to four times longer to be expressed and kill comparable numbers and 
types of target cells. The dose-response curves for viral glycoproteins in soluble form, 
inserted  into  vescicles,  or  in  the  whole  virion  were  equivalent  in  terms  of CMC 
induction. However, the activity of soluble glycoproteins and virions combined was 
TABLE  II 
Subsets of Nonspec~'c CMC 
CMG  Lysis of targets at$  Culture fluids 
Effector*  Inducer  2 h  4 h  8 h  18 h 
Anti-viral  Capacity to 
activity§  induce new 
CMC 
PBL  None (PBS)  Nil  Nil  2:  +  Nil  Nil 
PBL  Soluble  glycopro-  +  ++  +++  ++++  Nil  Nil 
reins 
PBL  Glycoproteins  in-  +  ++  +++  ++++  Nil  Nil 
seted  in  lipid  bi- 
layer 
PBL  Virions  Nil  Nil  +  ++++  ++++  ++++ 
* Fc  ÷ lymphocytes in both E- and E ÷ populations. 
:~ This evaluation is based on data from multiple quantitative experiments carried out under conditions 
similar to those described in Fig. 6, using ~Cr-labeled autologous or heterologous fibroblasts as targets. 
Relative  cytotoxic  index  with  a  value  of  1.0  being  maximum:  zt:, <0.1;  +,  0.1-0.25;  ++,  0.26-0.5; 
+++,  0.51-0.75; ++++,  0.76-1.0. 
§ Interferon activity as judged by inhibition of cytopathic effect of VSV on Vero ceils. CASALI, SISSONS, BUCHMEIER, AND OLDSTONE  851 
not additive but was intermediate between that of the two tested individually. This 
suggests  that  the  whole virion per se  might  hamper early CMC  induction  due to 
glycoproteins alone. It is likely that both reagents compete for the same receptors on 
the cell's surface. The fact that UV-inactivated virions perform in a manner similar 
to  their untreated  counterparts  suggests  that  replication of virus  is  not  needed  to 
inhibit early glycoprotein-induced CMC. 
Supernatant fluids from PBL cultured in the presence of soluble viral glycoproteins 
or glycoproteins inserted in a lipid bilayer with or without fibroblasts did not contain 
interferon or other factors able to induce unprimed lymphocytes to be cytotoxic. In 
contrast, culture fluids from PBL incubated with virions, containing an equivalent 
amount of viral glycoproteins on their surface, displayed antiviral activity and were 
able to recruit lymphocytes to be cytotoxic. 
Other experiments also indicate that  viral glycoproteins absorbed on target cells 
are sufficient to induce CMC.  Furthermore, the initiation of CMC activity by PBL 
with measles virus glycoproteins and virions was specific in that F(ab')2 antibody to 
measles virus glycoprotein blocked the induction of CMC by first binding to the virus 
glycoproteins or virion. This prevented their binding to PBL. However, once the PBL 
had been exposed to glycoproteins, the antibody had no effect on inhibiting CMC 
activity, suggesting that  glycoproteins, in  part, directly activate lymphocytes to be 
cytotoxic. There are  two recent studies  concerning glycoproteins and  activation of 
CMC in vitro. With PBL from humans, H~irfast et al. (36) showed that mumps virus 
glycoproteins prepared by trypsinization of the virion induced CMC  as did whole 
virions. With mouse PBL, an interferon-independent mechanism of activation of NK 
cells by alloantibodies with specificity for NK cells or by Helix pomatia lectin has been 
reported (37).  Culture fluids from lymphocytes activated by these stimuli also failed 
to recruit new cytotoxic lymphocytes. Hence, the CMC induced in mouse lymphocytes 
by Helix pomatia lectin or alloantibodies to NK cells appears similar to that reported 
here in human lymphocytes by viral glycoproteins. 
What  could be the biologic implications of our findings? Cytotoxic lymphocytes 
play an important role in limiting virus infection and in surveillance against  tumor 
cells,  and  by  their  lytic  action  also  cause  tissue  injury  that  can  harm  the  host. 
Experimental  models showed  that  cytotoxic lymphocytes generated  during a  viral 
infection in vivo can be segregated into two main sets.  One set  is immunologically 
specific in terms of activation, recognition, and killing of target cells. Included within 
this set are specific cytotoxic T lymphocytes (CTL) and lymphocytes that kill through 
the recognition and  binding of the Fc portion of specific anti-viral IgG  (antibody- 
dependent cell-mediated cytotoxicity [ADCC]). In vivo studies indicate that specific 
CTL and IgG antibodies are not generated until 5-7 d  after appropriate antigenic 
stimulation (38, 39). However, by this time the infecting virus can go through multiple 
cycles of replication (40). 
The second set of CMC is generated earlier in vivo, usually within the first 24 h of 
infection (41), but  lacks the fine target specificity shown by CTL and ADCC.  NK 
cells are part of this second set of early, unspecific CMC.  NK cells are generated in 
vitro within 6-12 h after exposure of PBL to virions, virus-infected, or tumor-bearing 
cells. NK cells segregate with the Fc receptor-bearing lymphocytes (42).  In vivo and 
in vitro induction of NK activity is associated with the release of interferon by PBL. 
From  the  data  in  this  paper,  viral  glycoprotein-induced CMC  may constitute an 852  INDUCTION  OF CYTOTOXIC LYMPHOCYTES BY VIRAL GLYCOPROTEINS 
earlier line of defense, because its expression occurs already within  2-4 h  after the 
exposure of lymphocytes to glycoproteins and interferon release is not required. Other 
experiments  (P.  Casali  and  M.  B. A.  Oldstone, manscript  in preparation)  indicate 
that  similar  to purified free glyeoproteins, fibroblasts expressing measles virus  HA 
and  F  polypeptides on their surfaces induce non-interferon-associated CMC within 
2-4 h of incubation with PBL. 
Thus, these early cellular mechanisms of defense against virus infection, comprising 
interferon-dependent as  well  as  interferon-independent CMC,  could  help  to  limit 
virus  spread  by  removing those  cells  that  would  otherwise later release  infectious 
virus. Uninfected bystander cells could be killed in the microenvironment where these 
cells are operating. The combined action of killer cells induced by virus glycoproteins, 
virions, and interferon may function to limit both the spread of virus and the numbers 
of infected cells in primary infections until specific CTL and antiviral antibodies are 
generated much later.  Failure of these early nonspecific defense mechanisms might 
favor the virulence of the virus over the host's immune system later in infection. 
Our  observatons  with  two  dissimiliar  RNA  viruses,  measles  virus  and  LCMV, 
suggest that other viruses may perform similarly. Future work will determine both the 
generalities of these findings for other viruses and its biological significance in vivo. 
Summary 
Purified hemagglutinin and fusion glycoproteins of measles virus either in soluble 
form or inserted in artifical membranes bind to human peripheral blood lymphocytes 
and  induce cell-mediated cytotoxicity (CMC)  in a  dose-response fashion.  Both au- 
tologous and heterologous noninfected target cells are lysed in vitro. The expression 
of CMC  is  not  inhibited  by  anti-measles  virus  antibody  added  to  lymphocytes 
previously exposed  to  viral  glycoproteins. The  killer  lymphocytes are  Fc  receptor 
positive, both erythrocyte-rosetting and non-erthrocyte-rosetting, as assessed by both 
positive and negative selection experiments. 
The induction of nonspeeific CMC by viral glycoproteins either in the soluble state 
or inserted into artificial membranes could be segregated from the CMC associated 
with  whole  virions.  First,  on  kinetics  studies,  purified  viral  glycoproteins induced 
CMC  more  rapidly  than  did  whole  virions.  Second,  viral  glycoprotein-produced 
response occurred in the absence of detectable release of interferon into the culture 
medium, whereas CMC activity due to whole virions was associated with interferon 
release.  The fact that  purified measles virus glycoproteins integrated into artificial 
membrane bilayers were as efficient as their soluble counterparts in inducing CMC 
suggests that  the hydrophobic portion of the glycoproteins was not  involved in the 
induction and expression of the lytic activity. Purified glycoproteins from lymphocytic 
choriomeningitis virus behave similarly, although this virus is unrelated to measles 
virus. It is inferred that interferon-independent CMC induced by viral glycoproteins 
might account for some of the biological reactions occurring early in the control of a 
viral infection. 
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